首页> 外文会议>Medical imaging >Multi-parametric MRI-Pathologic correlation of prostate cancer usingtracked biopsies
【24h】

Multi-parametric MRI-Pathologic correlation of prostate cancer usingtracked biopsies

机译:使用触发活检的前列腺癌的多参数MRI病理相关性

获取原文

摘要

MRI is currently the most promising imaging modality for prostate cancer diagnosis due to its high resolution and multi-parametric nature. However, currently there is no standard for integration of diagnostic information from different MRI sequences. We propose a method to increase the diagnostic accuracy of MRI by correlating biopsy specimens with four MRI sequences including T2 weighted MRI, Diffusion Weight Imaging, Dynamic Contrast Enhanced MRI and MRI spectroscopy. This method uses device tracking and image fusion to determine the specimen's position on MRI images. The proposed method is unbiased and cost effective. It does not substantially interfere with the standard biopsy workflow, allowing it to be easily accepted by physicians. A study of 41 patients was carried out to validate the approach. The performance of all four MRI sequences in various combinations is reported. Guidelines are given for multi-parametric imaging and tracked biopsy of prostate cancer.
机译:由于其高分辨率和多参数性质,MRI目前是前列腺癌诊断最有前景的成像模型。但是,目前没有从不同MRI序列集成诊断信息的标准。我们提出了一种通过将活检标本与四个MRI序列相关的活检标本相关,包括T2加权MRI,扩散重量成像,动态对比增强MRI和MRI光谱方法来提高MRI的诊断准确性。该方法使用设备跟踪和图像融合来确定样本在MRI图像上的位置。所提出的方法是无偏见和成本效益的。它基本上不会干扰标准的活检工作流程,使其容易被医生接受。对41名患者进行了研究以验证该方法。报告了各种组合中所有四种MRI序列的性能。给出了前列腺癌的多参数成像和跟踪活组织检查的指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号